May 12, 2022
Video
Before closing out their discussion on differentiated thyroid cancer, patients and health care professionals alike consider unmet needs in this space.
May 05, 2022
A brief discussion on therapeutic options one may consider after progression on lenvatinib therapy for iodine-refractory DTC.
Shared practical advice for patients who may be undergoing treatment for iodine-refractory differentiated thyroid cancer.
April 28, 2022
Discussion on how best to communicate with care providers while undergoing therapy for iodine-refractory differentiated thyroid cancer.
Checkmate: Beating Cancer at Its Own Game
The Value of Time in Cancer Care
Tecvayli Effective in BCMA-Pretreated R/R Multiple Myeloma
Blood Sugar Levels May Affect Cancer Outcomes in Patients With Diabetes